DEFR14A: SeaStar Medical Clarifies Share Count Ahead of Special Meeting

Sentiment:

Proxy Statement Amendment


SeaStar Medical Holding Corporation amends its proxy statement to clarify the number of outstanding shares as of January 31, 2025, before its Special Meeting of Stockholders.

Summary

  • SeaStar Medical Holding Corporation has filed an amendment to its proxy statement related to the upcoming Special Meeting of Stockholders.
  • The amendment clarifies the number of shares of common stock outstanding as of January 31, 2025, which is the record date for the Special Meeting.
  • As of the record date, there were 6,470,789 shares of Common Stock outstanding and entitled to vote at the Special Meeting.
  • The Special Meeting will be held virtually on March 20, 2025, at 10:00 a.m. Mountain Daylight Time.
  • The company completed a 25-for-1 reverse stock split on June 7, 2024, and all share and warrant information is presented on a post-split basis.
  • The company began mailing the Notice of Internet Availability of Proxy Materials on or about February 28, 2025.

Sentiment

Score: 7

Explanation: The document is a neutral, factual update regarding a procedural matter. It provides clarity and transparency to shareholders, which is generally viewed positively.

Positives

  • The company is providing clear information to shareholders regarding the number of outstanding shares.

Future Outlook

The document focuses on the procedural aspects of the upcoming Special Meeting and does not contain forward-looking statements about the company's future performance.

Industry Context

This is a standard proxy statement amendment related to a corporate action, which is common for publicly traded companies.

Stakeholder Impact

  • Shareholders are directly impacted by the information in the proxy statement, as it pertains to their voting rights and the upcoming Special Meeting.

Next Steps

  • Shareholders should review the amended proxy statement and vote on the proposals to be presented at the Special Meeting.

Key Dates

DateDescription
June 7, 2024Company completed a 25-for-1 reverse stock split
January 31, 2025Record Date for the Special Meeting
February 28, 2025Original Proxy Statement Date
February 28, 2025Company began mailing the Notice of Internet Availability of Proxy Materials
March 20, 2025Date of the Special Meeting of Stockholders

Keywords

Proxy Statement, Special Meeting, Shareholders, Common Stock, SeaStar Medical, Amendment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.